Free Trial
→ Elon Takes Aim at Social Security (From Altimetry) (Ad) Free ENLV Stock Alerts

Enlivex Therapeutics (ENLV) SEC Filings & 10K Form

Enlivex Therapeutics logo
$1.00 -0.01 (-1.32%)
As of 02/21/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Recent Enlivex Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
02/18/2025
5:22 AM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2025
4:43 PM		ARMISTICE CAPITAL, LLC (Filed by)
Enlivex Therapeutics Ltd. (Subject)
Enlivex Therapeutics (Subject)
Form SCHEDULE 13G/A
12/11/2024
7:33 AM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/03/2024
7:32 AM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/29/2024
3:30 PM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/20/2024
7:02 AM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2024
7:01 AM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/31/2024
3:05 PM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/30/2024
7:01 AM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2024
5:03 AM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K/A
09/26/2024
7:32 AM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/24/2024
7:33 AM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/11/2024
7:30 AM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/23/2024
7:02 AM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/24/2024
7:02 AM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/20/2024
7:04 AM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/17/2024
7:03 AM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/14/2024
3:30 PM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/03/2024
7:05 AM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2024
7:13 AM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2024
7:01 AM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/22/2024
7:02 AM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/16/2024
7:00 AM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/11/2024
7:13 AM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/29/2024
3:30 PM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:ENLV) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners
The Real Hillbilly Elegy
The mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...
Porter & Company | Sponsored
Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”
Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. ...
Colonial Metals | Sponsored
Elon’s “New Gold”
MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...
True Market Insiders | Sponsored
$5,000 DOGE check?
Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a porti...
Altimetry | Sponsored
This Crypto Is Set to Explode in February
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...
Crypto 101 Media | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Buy this AI Stock Before Elon’s Announcement
With Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...
InvestorPlace | Sponsored
Buy NVDA Now?
After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...
Chaikin Analytics | Sponsored